These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37029840)

  • 21. Vaterite vectors for the protection, storage and release of silver nanoparticles.
    Ferreira AM; Vikulina A; Cave GWV; Loughlin M; Puddu V; Volodkin D
    J Colloid Interface Sci; 2023 Feb; 631(Pt A):165-180. PubMed ID: 36375299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel In Vivo Assessment of Antimicrobial Efficacy of Ciprofloxacin Loaded Mesoporous Silica Nanoparticles against
    Alandiyjany MN; Abdelaziz AS; Abdelfattah-Hassan A; Hegazy WAH; Hassan AA; Elazab ST; Mohamed EAA; El-Shetry ES; Saleh AA; ElSawy NA; Ibrahim D
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337154
    [No Abstract]   [Full Text] [Related]  

  • 23. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ternary nanoparticle complex of antibiotic, polyelectrolyte, and mucolytic enzyme as a potential antibiotic delivery system in bronchiectasis therapy.
    Tran TT; Hadinoto K
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111095. PubMed ID: 32416520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functionalization of ZnO Nanoparticles by Glutamic Acid and Conjugation with Thiosemicarbazide Alters Expression of Efflux Pump Genes in Multiple Drug-Resistant
    Nejabatdoust A; Zamani H; Salehzadeh A
    Microb Drug Resist; 2019 Sep; 25(7):966-974. PubMed ID: 30855211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated stability evaluation and in vitro antimicrobial activity of a preformed ciprofloxacin nanocrystal formulation.
    Mujtaba MA
    Pak J Pharm Sci; 2023 Jan; 36(1):211-216. PubMed ID: 36967514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultralong Hydroxyapatite Nanowires-Based Paper Co-Loaded with Silver Nanoparticles and Antibiotic for Long-Term Antibacterial Benefit.
    Xiong ZC; Yang ZY; Zhu YJ; Chen FF; Zhang YG; Yang RL
    ACS Appl Mater Interfaces; 2017 Jul; 9(27):22212-22222. PubMed ID: 28654270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antibacterial activity of Egyptian local insects' chitosan-based nanoparticles loaded with ciprofloxacin-HCl.
    Marei N; Elwahy AHM; Salah TA; El Sherif Y; El-Samie EA
    Int J Biol Macromol; 2019 Apr; 126():262-272. PubMed ID: 30584935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin-Loaded Gold Nanoparticles against Antimicrobial Resistance: An In Vivo Assessment.
    Nawaz A; Ali SM; Rana NF; Tanweer T; Batool A; Webster TJ; Menaa F; Riaz S; Rehman Z; Batool F; Fatima M; Maryam T; Shafique I; Saleem A; Iqbal A
    Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin-intercalated layered double hydroxide-in-hybrid films as composite dressings for controlled antimicrobial topical delivery.
    Salguero Y; Valenti L; Rojas R; García MC
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110859. PubMed ID: 32279819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
    World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli.
    Khare T; Mahalunkar S; Shriram V; Gosavi S; Kumar V
    Environ Res; 2021 Aug; 199():111321. PubMed ID: 33989619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEG-PLGA nanoparticles for encapsulating ciprofloxacin.
    Watcharadulyarat N; Rattanatayarom M; Ruangsawasdi N; Patikarnmonthon N
    Sci Rep; 2023 Jan; 13(1):266. PubMed ID: 36609594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Self-Assembled Polycaprolactone-Lipid Hybrid Nanoparticles Enhance the Antibacterial Activity of Ciprofloxacin.
    Omer ME; Halwani M; Alenazi RM; Alharbi O; Aljihani S; Massadeh S; Al Ghoribi M; Al Aamery M; Yassin AE
    SLAS Technol; 2020 Dec; 25(6):598-607. PubMed ID: 32734812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel gel based on an ionic complex from a dendronized polymer and ciprofloxacin: Evaluation of its use for controlled topical drug release.
    García MC; Cuggino JC; Rosset CI; Páez PL; Strumia MC; Manzo RH; Alovero FL; Alvarez Igarzabal CI; Jimenez-Kairuz AF
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():236-46. PubMed ID: 27612709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
    Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K
    Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
    Ahire JJ; Neveling DP; Hattingh M; Dicks LM
    PLoS One; 2015; 10(4):e0123648. PubMed ID: 25853255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
    Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-Time Monitoring of
    Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
    Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM
    Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.